News
01.02.2019
We are excited to inform you that ARNA Genomics US Inc. has been qualified for participation in Softlanding Program in Germany. Participation in this program will allow company to gain […]
31.12.2018
Dear colleagues and friends! In anticipation of the upcoming new 2019, we would like to take summarise results of our work in 2018 and share with you some our plans. […]
15.11.2018
During the XXII Russian Oncological Congress professor of Sechenov Medical University, Head of Personalized Oncology Center “OncoTarget”, Marina Sekacheva, presented the results of a proof-of-concept ARNA Breast Cancer test. Results […]
14.11.2018
ARNA Genomics CEO Egor Melnikov took part in the discussion “Clinical research of medical devices” at the 7th international forum “Clinical research in Russia”. During the discussion, it was possible […]
13.11.2018
ARNA Genomics will take part in the XXII Russian Oncological Congress, which will be held from November 13 to 15 in Crocus Expo, Moscow. Our booth is located within the […]
18.10.2018
ARNA Genomics participated in the BIO Investor Forum – 25th years of innovation, which was held in San Francisco. During the event, the company presented its own technology to investors, […]